Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It places an enormous burden on the patients, caregivers and the society at large. As a chronic illness, AF accrues significant costs related to clinical presentation, complications and loss of productivity. Novel invasive approaches to AF promise a cure in some patients and a significant reduction in AF burden in others, but are very expensive. This paper will address the cost of conventional and invasive strategies in AF care and will review the evidence on the comparative cost effectiveness of these approaches. © 2012 Bentham Science Publishers.
CITATION STYLE
Khaykin, Y., & Shamiss, Y. (2012). Cost of Atrial Fibrillation: Invasive vs Non-Invasive Management in 2012. Current Cardiology Reviews, 8(4), 368–373. https://doi.org/10.2174/157340312803760730
Mendeley helps you to discover research relevant for your work.